Back to the feed
In brief
On 17.09.2026, a person holding the function "Executive member of the board of directors / senior management" at Kuros Biosciences AG disclosed a purchase worth CHF 115’322 to SIX Exchange Regulation.
This is the largest management purchase disclosed at Kuros Biosciences AG over the previous 12 months (3 purchases in total).
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A executive member of the board of directors / senior management of Kuros Biosciences AG declared a "Purchase" transaction on 17.09.2026.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date17.09.2026
Issuing companyKuros Biosciences AG
ISINCH0325814116
Transaction sidePurchase
Management functionExecutive member of the board of directors / senior management
Security typeRegistered shares
Quantity76’024
Unit priceCHF 1.52
AmountCHF 115’322
ConditionsExercise and hold of call options
ExchangeXSWX
Notification IDT1Q9H00045
Other Kuros Biosciences AG insider transactions
- Purchase · Executive member of the board of directors / senior management19.10.2026CHF 282’505
- Sale · Executive member of the board of directors / senior management06.10.2026CHF 552’000
- Purchase · Executive member of the board of directors / senior management22.09.2026CHF 30’600
- Sale · Executive member of the board of directors / senior management26.05.2026CHF 139’385
- Purchase · Executive member of the board of directors / senior management16.03.2026CHF 65’224
These figures aggregate public disclosures. They are not investment advice.